Results 171 to 180 of about 13,730,156 (351)

Gavin Slade, Reorganizing crime: Mafia and anti-Mafia in post-Soviet Georgia

open access: yesJournal of Power Institutions in Post-Soviet Societies, 2016
Matthew Light
doaj  

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Roy Allison, Russia, the West, and Military Intervention

open access: yesJournal of Power Institutions in Post-Soviet Societies, 2016
Matthew Light
doaj  

Adaptation and Plasticity of <i>Nannochloropsis</i> sp. in Response to Seasonal and Geographic Climate Variation. [PDF]

open access: yesEvol Appl
Echenique-Subiabre I   +10 more
europepmc   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla   +15 more
wiley   +1 more source

All-optical processors by 3D printable photochromic materials. [PDF]

open access: yesLight Sci Appl
D'Elia F   +4 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy